Exchange: TSXV·Updated 03:59 PM EDT

RX.TSXV BioSyent Inc.

$17.15
$0.235
(1.39%)
Today
EarningsNov 19
Mkt Cap$191.29M
Vol2,466.00

About RX.TSXV

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include Cathejell Jelly, FeraMAX Pd Therapeutic 150, FeraMAX Pd Powder 15, Proktis-M, RepaGyn, and cTIBELLA. The company was founded on April 28, 1947 and is headquartered in Mississauga, Canada.
50

Sentiment

How do you feel about RX.TSXV?

Advertisement|Remove ads.